Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 2Thoracic 1Sarcoma 1Genitourinary 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2727Lung Neoplasms 944Small Cell Lung Carcinoma 447Neoplasms 419Colorectal Neoplasms 407Breast Neoplasms 355Melanoma 332Ovarian Neoplasms 316Neoplasm Metastasis 280Pancreatic Neoplasms 251Squamous Cell Carcinoma of Head and Neck 232Stomach Neoplasms 227Carcinoma, Renal Cell 214Triple Negative Breast Neoplasms 189Head and Neck Neoplasms 178Prostatic Neoplasms 152Esophageal Neoplasms 149Endometrial Neoplasms 145Uterine Cervical Neoplasms 139Urinary Bladder Neoplasms 132Mesothelioma 115Carcinoma 106Carcinoma, Hepatocellular 104Colonic Neoplasms 103Carcinoma, Transitional Cell 99Sarcoma 98Kidney Neoplasms 74Mesothelioma, Malignant 72Cholangiocarcinoma 67Liver Neoplasms 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Adenocarcinoma, Mucinous × Thoracic × Clear all
NCT04665921 2025-02-07

A Study of SGN-STNV in Advanced Solid Tumors

Seagen Inc.

Phase 1 Terminated
111 enrolled
GastrointestinalGynecologicThoracic

Adenocarcinoma, Mucinous, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡